Literature DB >> 2438305

Tissue plasminogen activator promotes platelet disaggregation in plasma.

J Loscalzo, D E Vaughan.   

Abstract

We studied the disaggregation of human platelets by tissue-type plasminogen activator (t-PA). When added to a suspension of human platelets induced to aggregate in plasma with adenosine 5'-diphosphate, t-PA promoted disaggregation of platelets over several minutes. Addition of fresh plasma or purified human fibrinogen to disaggregated platelets facilitated (reversible) aggregation and subsequent disaggregation. Aspirin treatment of platelets markedly potentiated the ability of t-PA to induce disaggregation. Disaggregation was inhibited by alpha-2-antiplasmin. Comparative analysis of the rate of proteolysis of platelet-bound fibrinogen with that of ambient plasma fibrinogen suggested that fibrinogenolysis of cohesive fibrinogen occurred more rapidly than fibrinogenolysis of ambient fibrinogen. These data demonstrate that t-PA facilitates platelet disaggregation in plasma through kinetically selective proteolysis of cohesive fibrinogen by plasmin, and suggest that thrombolytic mechanisms may serve both to remove platelets from platelet-fibrin thrombi and to disperse circulating platelet aggregates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438305      PMCID: PMC424517          DOI: 10.1172/JCI113015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.

Authors:  K K Wu; J C Hoak
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

2.  Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death.

Authors:  J W Haerem
Journal:  Atherosclerosis       Date:  1974 May-Jun       Impact factor: 5.162

3.  Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease.

Authors:  J W Haerem
Journal:  Atherosclerosis       Date:  1972 Mar-Apr       Impact factor: 5.162

4.  Iodination of the human platelet membrane. Studies of the major surface glycoprotein.

Authors:  R L Nachman; A Hubbard; B Ferris
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

5.  Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane.

Authors:  D R Phillips
Journal:  Biochemistry       Date:  1972-11-21       Impact factor: 3.162

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  Plasmin inhibition of thrombin-induced platelet aggregation.

Authors:  J L Miller; A J Katz; M B Feinstein
Journal:  Thromb Diath Haemorrh       Date:  1975-04-30

10.  Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.

Authors:  S Niewiarowski; A F Senyi; P Gillies
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more
  19 in total

1.  Guidelines for the Management of Patients with Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

2.  Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.

Authors:  D E Vaughan; P J Declerck; M De Mol; D Collen
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 3.  Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation.

Authors:  M S el-Sayed
Journal:  Sports Med       Date:  1996-11       Impact factor: 11.136

Review 4.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 5.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 6.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

Review 7.  Plasminogen receptors: the first quarter century.

Authors:  Lindsey A Miles; Robert J Parmer
Journal:  Semin Thromb Hemost       Date:  2013-03-26       Impact factor: 4.180

Review 8.  Thrombolytic therapy in the treatment of stroke.

Authors:  G J del Zoppo
Journal:  Drugs       Date:  1997       Impact factor: 9.546

9.  Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator.

Authors:  J Loscalzo
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.

Authors:  J S Stamler; D I Simon; O Jaraki; J A Osborne; S Francis; M Mullins; D Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.